Search
for
Sort by
Research 181–210 of 1000+
- Why Odds Ratios Can Be Tricky Statistics
- (798) Finasteride 1 mg: Silent Impacts on Male Fertility Despite Preserved Hormonal Balance
- Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review.
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Gas-propelled anti-hair follicle aging microneedle patch for the treatment of androgenetic alopecia
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Hur effektivt är finasteridbehandling mot ärftligt manligt håravfall
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Guidelines on the use of finasteride in androgenetic alopecia
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- The Impact of Metformin on Plasma Prolactin Levels in Antipsychotics‐Treated Men With Hyperprolactinemia and Early‐Onset Androgenic Alopecia
- Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride − 5% Minoxidil in male androgenetic alopecia
- Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia
- Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- From bench to babies – drug development for male subfertility
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- Endocrinology
- Phamacopuncture and Dermal Application of Sebalgukhwa-san: Effects on Hair Growth in a Mouse Model of Alopecia
- Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence